Sintilimab Versus Mitomycin in Combination With Capecitabine and IMRT for Limited-stage Anal Squamous Cell Carcinoma
Clinical trial NCT07692152 · RECRUITING
Trial details
- NCT number
- NCT07692152
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-17
- Primary completion
- 2029-03-01
- Enrollment
- 350
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.